TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Retail Clinics Move to Treat Illnesses Retail health clinics are adding treatments for chronic diseases to their repertoire, hoping to find steadier revenue, but putting the clinics into greater competition with hospitals. online.barrons.com |
A Mixed Bag for Traders and Investors in Healthcare As futures for the Dow Jones industrial average, the S&P 500 and the Nasdaq 100 are all pointing to a higher opening on Monday, it's important to note that we are starting a busy week of earnings, and that could be a mixed bag for traders and investors. Last week, the five day trading stretch ended with some drops in stock prices among some familiar names. Let's begin with Acorda Therapeutics (NASDAQ:ACOR) whose shares dropped -21.36%, after the U.S. Food and Drug Administration (FDA) posted on its website briefing documents for the Peripheral and Central Nervous System Drugs Advisory Committee meeting to review Acorda’s New Drug Application (NDA) for Fampridine-SR for the proposed indication of improvement of walking ability in people with multiple sclerosis (MS).Complete Story » seekingalpha.com |
WellPoint Profit Drops Amid Write-Downs WellPoint's profit fell 11% amid declining enrollments and asset write-downs. The health insurer raised its 2009 revenue estimates and affirmed its earnings view. online.barrons.com |
Emerging Stock Report Initiates Independent Research Coverage on Array BioPharma Inc. (GlobeNewswire) CALGARY, Alberta -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Array BioPharma Inc., . Emerging Stock Report is currently offering a complimentary trial subscription to the investment community. us.rd.yahoo.com |
Waters Corporation Q4 2009 Earnings Call Transcript Waters Corporation (WAT)Q4 2009 Earnings CallJanuary 26, 2010 8:30 am ETComplete Story » seekingalpha.com |